Neumora Therapeutics, Inc. · NASDAQ:NMRA
Aurora Daljit Singh sold 176,060 Neumora Therapeutics, Inc. shares (Form 4)
Traded Aug 20 to Aug 21, 2026 · Filed Aug 21, 2026
From Aug 20 to Aug 21, 2026, Aurora Daljit Singh (See Remarks) sold 176,060 Neumora Therapeutics, Inc. shares at an average US$1.53 for US$269K, leaving 0 shares. Filed Aug 21, 2026 (Form 4).
- Sold
- 176,060 shares
- Price
- US$1.53 average (US$1.51 to US$1.60)
- Value
- US$269K
- Holding after
- 0 shares (held indirectly)
- Trading plan
- No
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Common Stock | Option exercise | 67,741 | US$0.72 | 116,491 | Direct |
| Aug 20, 2026 | Common Stock | Sale | 67,741 | US$1.51 | 48,750 | Direct |
| Aug 20, 2026 | Common Stock | Option exercise | 21,685 | US$0.72 | 21,685 | Indirect |
| Aug 20, 2026 | Common Stock | Option exercise | 45,026 | US$0.72 | 66,711 | Indirect |
| Aug 20, 2026 | Common Stock | Sale | 66,711 | US$1.51 | 0 | Indirect |
| Aug 21, 2026 | Common Stock | Option exercise | 20,553 | US$0.72 | 69,303 | Direct |
| Aug 21, 2026 | Common Stock | Sale | 20,553 | US$1.59 | 48,750 | Direct |
| Aug 21, 2026 | Common Stock | Option exercise | 21,055 | US$0.72 | 21,055 | Indirect |
| Aug 21, 2026 | Common Stock | Sale | 21,055 | US$1.60 | 0 | Indirect |
Source
Related
- Neumora Therapeutics, Inc.
- Aurora Daljit Singh
- Neumora Therapeutics, Inc. shareholders
- Form 4 · Aurora Daljit Singh · Aug 19, 2026
- Schedule 13G/A · K2 HealthVentures Equity Trust LLC · May 15, 2026
- Schedule 13G/A · Invus Public Equities, L.P. · May 4, 2026
- Schedule 13D/A · Burow Kristina · Apr 1, 2026
- Schedule 13G · Invus Public Equities, L.P. · Feb 19, 2026
- Schedule 13G/A · K2 HealthVentures Equity Trust LLC · Feb 17, 2026